FI922874A7 - Aminometyyli-substituoituja 2,3-dihydropyrano/2,3-b/pyridiinejä, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa - Google Patents

Aminometyyli-substituoituja 2,3-dihydropyrano/2,3-b/pyridiinejä, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa Download PDF

Info

Publication number
FI922874A7
FI922874A7 FI922874A FI922874A FI922874A7 FI 922874 A7 FI922874 A7 FI 922874A7 FI 922874 A FI922874 A FI 922874A FI 922874 A FI922874 A FI 922874A FI 922874 A7 FI922874 A7 FI 922874A7
Authority
FI
Finland
Prior art keywords
dihydropyrano
pyridines
aminomethyl
pharmaceuticals
substituted
Prior art date
Application number
FI922874A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI922874L (fi
FI922874A0 (fi
Inventor
Dieter Arlt
Hans-Georg Heine
Thomas Glaser
Vry Jean Marie Viktor De
Rudolf Schohe-Loop
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI922874A0 publication Critical patent/FI922874A0/fi
Publication of FI922874L publication Critical patent/FI922874L/fi
Publication of FI922874A7 publication Critical patent/FI922874A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI922874A 1991-06-20 1992-06-18 Aminometyyli-substituoituja 2,3-dihydropyrano/2,3-b/pyridiinejä, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa FI922874A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4120322A DE4120322A1 (de) 1991-06-20 1991-06-20 Aminomethyl-substituierte 2,3-dihydropyrano(2,3-b)pyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Publications (3)

Publication Number Publication Date
FI922874A0 FI922874A0 (fi) 1992-06-18
FI922874L FI922874L (fi) 1992-12-21
FI922874A7 true FI922874A7 (fi) 1992-12-21

Family

ID=6434336

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922874A FI922874A7 (fi) 1991-06-20 1992-06-18 Aminometyyli-substituoituja 2,3-dihydropyrano/2,3-b/pyridiinejä, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa

Country Status (24)

Country Link
US (1) US5250540A (en:Method)
EP (1) EP0519291B1 (en:Method)
JP (1) JP3135170B2 (en:Method)
KR (1) KR930000520A (en:Method)
CN (1) CN1067656A (en:Method)
AT (1) ATE147388T1 (en:Method)
AU (1) AU649331B2 (en:Method)
CA (1) CA2071398A1 (en:Method)
CZ (1) CZ177892A3 (en:Method)
DE (2) DE4120322A1 (en:Method)
DK (1) DK0519291T3 (en:Method)
ES (1) ES2095984T3 (en:Method)
FI (1) FI922874A7 (en:Method)
GR (1) GR3022557T3 (en:Method)
HU (1) HU209890B (en:Method)
IE (1) IE922004A1 (en:Method)
IL (1) IL102227A0 (en:Method)
MX (1) MX9202983A (en:Method)
NO (1) NO922198L (en:Method)
NZ (1) NZ243191A (en:Method)
RU (1) RU2044737C1 (en:Method)
SK (1) SK177892A3 (en:Method)
TW (1) TW221439B (en:Method)
ZA (1) ZA924517B (en:Method)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU228673B1 (en) * 1993-08-19 2013-05-28 Janssen Pharmaceutica Nv Vasoconstrictive substituted dihydropyranopyridines, process for producing them and pharmaceutical compositions containing them
DE4444288A1 (de) * 1994-12-13 1996-06-20 Rainer Dr Med Etzel Verwendung von Weihrauch zur Behandlung der Alzheimer-Krankheit
SK1022000A3 (en) 1997-07-31 2000-09-12 Du Pont Pharm Co A process for the preparation of cyclopropylacetylene
DE19742508A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
US6235957B1 (en) 1998-06-29 2001-05-22 Dupont Pharmaceuticals Company Process for the preparation of cyclopropylacetylene
WO2000000472A1 (en) 1998-06-30 2000-01-06 Du Pont Pharmaceuticals Company 5-ht7 receptor antagonists
US6359164B1 (en) 1998-10-01 2002-03-19 Zhe Wang Process for the preparation of cyclopropylacetylene
US6288297B1 (en) 1998-10-01 2001-09-11 Dupont Pharmaceuticals Company Process for the preparation of cyclopropylacetylene
JP2001131177A (ja) * 1999-11-08 2001-05-15 Ohara Yakuhin Kogyo Kk ジベンズ［ｃ，ｆ］イミダゾ［１，５−ａ］アゼピンの製造方法及びその製造中間体
DE10232113A1 (de) * 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
US4748182A (en) * 1986-03-05 1988-05-31 Merrell Dow Pharmaceuticals Inc. Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents
DE3718317A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
CA2015296C (en) * 1989-05-31 2001-08-07 Karnail Atwal Pyranyl cyanoguanidine derivatives
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.

Also Published As

Publication number Publication date
FI922874L (fi) 1992-12-21
EP0519291A1 (de) 1992-12-23
ZA924517B (en) 1993-03-31
AU649331B2 (en) 1994-05-19
DE59207824D1 (de) 1997-02-20
ES2095984T3 (es) 1997-03-01
KR930000520A (ko) 1993-01-15
GR3022557T3 (en) 1997-05-31
NZ243191A (en) 1994-04-27
DE4120322A1 (de) 1992-12-24
IL102227A0 (en) 1993-01-14
NO922198D0 (no) 1992-06-04
NO922198L (no) 1992-12-21
HU209890B (en) 1994-11-28
HU9202066D0 (en) 1992-09-28
AU1739292A (en) 1992-12-24
HUT64959A (en) 1994-03-28
SK177892A3 (en) 1995-03-08
TW221439B (en:Method) 1994-03-01
CA2071398A1 (en) 1992-12-21
FI922874A0 (fi) 1992-06-18
MX9202983A (es) 1992-12-01
DK0519291T3 (da) 1997-06-09
JP3135170B2 (ja) 2001-02-13
US5250540A (en) 1993-10-05
CN1067656A (zh) 1993-01-06
RU2044737C1 (ru) 1995-09-27
JPH05202054A (ja) 1993-08-10
EP0519291B1 (de) 1997-01-08
CZ177892A3 (en) 1993-02-17
ATE147388T1 (de) 1997-01-15
IE922004A1 (en) 1992-12-30

Similar Documents

Publication Publication Date Title
FI884947A7 (fi) Tetrahydro-furo- ja -tieno/2,3-c/pyridiinit, niiden käyttö lääkeaineina ja menetelmä niiden valmistamiseksi
EP0412798A3 (en) Substituted pyridines, their preparation, formulations and use in dementia
IL98472A0 (en) Dialkoxy-pyridinyl-benzimidazole derivatives,process for their preparation and their pharmaceutical use
LTIP1713A (en) Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
EP0259804A3 (en) Pyridoû3,2,1-ij¨-1,3,4-benzoxadiazine derivatives, process for their preparation, resulting pharmaceutical preparations and intermediates for use in the process
DE69228142D1 (de) Pyrolo[2,3-b]pyridine mit therapeutischer Wirkung und Verfahren zu deren Herstellung
FI960160A7 (fi) Imidatso/1,2-a/pyratsin-4-onijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet
EE9900155A (et) 1H-pürido[3,4-b]indool-4-karboksamiidi derivaadid, nende valmistamismeetod ja kasutamine raviks
FI924164A7 (fi) 2-hydroksimetyylipyridiinit, vastaavat pyridiini-N-oksidit ja niiden johdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
EP0449026A3 (en) Desoxynojirimycin derivatives, process for their preparation and their use in drugs
FI911615A7 (fi) Uusia 4-kinolyyli-dihydropyridiinejä, menetelmiä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
ZA926969B (en) New beta-carboline derivatives, their production and use in pharmaceutical agents.
FI925825A7 (fi) Substituoidut pyridiini-N-oksidit, menetelmä niiden valmistamiseksi sekä niiden käyttö
FI895288A7 (fi) 1,2,3,4-tetrahydro-1,9-akridiiniamiineja, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
FI941912A7 (fi) 3-kinolyylillä substituoidut dihydropyridiinit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
ZA924127B (en) New hetaryloxy-beta-carbolines,their production and use in pharmaceutical agents
FI885056A7 (fi) Uusia fluorimetoksifenyylidihydropyridiinejä, menetelmiä niiden valmistamiseksi ja niiden käyttö lääkkeissä
FI902901A7 (fi) Dibentsoli/1,5/dioksosiini-5-oni-johdannaisia, niiden käyttö lääkeaineissa ja menetelmä niiden valmistamiseksi
DK3290A (da) Substituerede pyrido(2,3-d)pyrimidiner, deres fremstilling og anvendelse i laegemidler
IL101617A0 (en) 2-aminopyrimidine-4-carboxamide derivatives,their preparation and their application in therapy
FI921456A7 (fi) Substituoituja 2',3'-didesoksi-5-trifluorimetyyliuridiineja, menetelmiä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
FI925639A7 (fi) Isoksatsolyyli-imidatsolijohdannaisia, menetelmä niiden valmistamiseks i ja niiden käyttö lääkeaineissa
FI924167A7 (fi) Indolisulfonamidilla substituoidut dihydropyridiinit, menetelmä niidenvalmistamiseksi ja niiden käyttö lääkeaineissa
FI955141A7 (fi) Pyrido(1,2,3-de)kinoksaliinijohdannaisia, menetelmä niiden valmistamis eksi ja niiden käyttö lääkkeissä
FI915025A7 (fi) 8-atsabisyklo(3,2,1)oktyylialkyylitiatsolidinoneja, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineina